04Recent Activity
Participated in Simile's Series B at a $2B valuation led by Greenoaks, A*'s third investment in the company after co-leading its seed round.
JUL 30, 2026
Simile
Simile.ai specializes in AI simulations, creating generative agents that accurately represent real individuals to simulate human behavior in various scenarios. The company has partnered with CVS Health to enhance decision-making processes through simulations.